Long-term survival can be achieved in a significant fraction of older patients with core binding factor acute myeloid leukemia treated with intensive chemotherapyFederico Mosna, Michele Gottardi, Cristina Papayannidis et al.|Haematologica|2024Cited by 4
Measurable Residual Disease Monitoring for Philadelphia Positive Acute Lymphoblastic Leukemia (Ph+ALL) in the Setting of the Gimema ALL2820 TrialMarco Beldinanzi, Sabina Chiaretti, Vittorio Bellomarino et al.|Blood|2024Cited by 0